Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide changes that equation entirely
Weighing these factors against personal goals is essential
Food and Drug Administration (FDA) approved the semaglutide-based drug Wegovy for obesity
Wegovy is a GLP-1 receptor agonist, while Mounjaro targets both GLP-1 and GIP receptors, which may offer added benefits for some individuals
The FDA also warns not to take Trulicity if you have a personal or family history of multiple endocrine neoplasia syndrome Type 2, medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis
Understanding how long you might stay on treatment helps set appropriate expectations from the beginning
US$ 23.30
US$ 20.58
US$ 21.51
US$ 26.49
US$ 22.93
US$ 20.25
US$ 27.82
